INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA

$2,231,082P01FY2012HLNIH

University Of California, San Francisco, San Francisco CA

Investigators

Linked publications, trials & patents

Paper 38889046 Paper 38724552 Paper 38651338 Paper 38127464 Paper 38127070 Paper 38113166 Paper 38062486 Paper 37862171 Paper 37599172 Paper 37587279 Paper 37547023 Paper 37291214 Paper 37044061 Paper 36993421 Paper 36736797 Paper 36388982 Paper 36351364 Paper 36303018 Paper 36044899 Paper 35876128 Paper 35857635 Paper 35608904 Paper 35446623 Paper 35355021 Paper 35347136 Paper 35322214 Paper 35245089 Paper 35176675 Paper 35148488 Paper 35139352 Paper 35104436 Paper 34982656 Paper 34931858 Paper 34586363 Paper 33974563 Paper 33883027 Paper 33852849 Paper 33682796 Paper 33536623 Paper 33419885 Paper 33330868 Paper 33290280 Paper 33264610 Paper 33046696 Paper 32511326 Paper 32427931 Paper 32348692 Paper 32031571 Paper 31978350 Paper 31866436 Paper 31844841 Paper 31596609 Paper 31433990 Paper 31152051 Paper 31128962 Paper 31114038 Paper 30930175 Paper 30431352 Paper 30379593 Paper 30371106 Paper 30201992 Paper 30142344 Paper 30022164 Paper 30021144 Paper 29959948 Paper 29956162 Paper 29950724 Paper 29887373 Paper 29723043 Paper 29599193 Paper 29524537 Paper 29400693 Paper 29161085 Paper 29122948 Paper 29080709 Paper 29064281 Paper 28911920 Paper 28833774 Paper 28663322 Paper 28607111 Paper 28506464 Paper 28448060 Paper 28431248 Paper 28011865 Paper 28005426 Paper 27749840 Paper 27699235 Paper 27525310 Paper 27478182 Paper 27432971 Paper 27401625 Paper 27128698 Paper 27037311 Paper 27027957 Paper 26850657 Trial NCT05748912 Trial NCT04628442 Trial NCT04514926 Trial NCT04514913 Trial NCT00596232

Abstract

This proposal for a collaborative Program Project Grant (PPG) focuses on mechanisms of TH2 inflammation in asthma. The unifying hypotheses are: (i) TH2 inflammation underlies the most common molecular phenotypes of asthma; (11) Epithelial cells secrete cytokines and chemokines to initiate and amplify TH2 inflammation in the airway; (ill) Innate helper type 2 (IH2) cells and CD4+T cells are key cellular targets of epithelial cytokines and chemokines and principal sources of TH2 cytokines in the airway. Project 1 will focus on the role of iH2 cells as proximal regulators of TH2 inflammation in the airway. This project proposes to characterize markers for these cells, delineate their role in allergic airway responses and collaborate with investigators in Project 3 to advance understanding of iH2 cells in human asthma. Project 2 will identify the miRNAs that regulate helper T cell functions relevant to asthma, examine miRNA expression patterns in CD4+T cells and iH2 cells in clinical samples from asthmatic patients, and characterize the mRNA targets and In vivo function of select miRNAs. Project 3 will investigate the role of Innate helper type 2 cells as cellular mediators of TH2-high asthma, determine how IL-33 amplifies TH2 inflammation in acute severe asthma, and explore how genetic variation in ST2 modulates airway TH2 inflammation in asthma. These projects will be supported by three cores, which will provide administrative support, access to high quality biospecimens from well-characterized asthmatic subjects and healthy controls, and expert biostatistical and bioinformatic support. The PPG represents a collaborative program of research that brings together mechanism-oriented clinical researchers from UCSF's Airway Clinical Research Center (ACRC) (Fahy and Woodruff) with disease-oriented basic immunologists from UCSF's Sandler Asthma Basic Research Center (SABRE) (Locksley and Ansel) Together, these investigators will work collaboratively using a variety of experimental approaches. Including studies in human biospecimens in a PPG that promises to advance understanding of airway TH2 inflammation in ways that are highly relevant to patients with asthma.

View original record on NIH RePORTER →